Improve Your Clinical Trial Outcomes with the Lab of the Future

Each year on May 20th, International Clinical Trials Day is celebrated in memory of James Lind, who started what is often considered the first randomized clinical trial aboard a ship in 1747.  

In recognition of International Clinical Trials Day 2017, Costa Panagos, Chief Executive Officer, Q2 Solutions, explains how we are creating the lab of the future to help our customers bring new medicines to market faster in:
  • Our CEO Brand Introduction Video - Learn how we help our customers improve human health through innovation that transforms science and data into actionable medical insights.
  • Our Lab of the Future Insight Brief - Our commitment to innovation is how we’re building a better laboratory solution for our customers’ clinical trials – we call it “the lab of the future.” Learn how our lab of the future model better meets the needs of patients, sites, and sponsors. 
Contact us directly to learn how our lab of the future model can help enhance your clinical trial experience.

About the Speaker:

Costa Panagos, Chief Executive Officer, Q2 Solutions

Costa PanagosCosta Panagos is chief executive officer and Board member of Q2 Solutions, a Quintiles Quest joint venture. Launched in 2015, Q2 Solutions is a leading global clinical trials laboratory services organization. The company helps biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. 

Previously, Costa was senior vice president and global head of QuintilesIMS’ Global Laboratories, which included its Central Laboratory, BioAnalytical and ADME operations as well as its Cardiac Safety Services organization. During his more than 15-year career at QuintilesIMS, Costa has held several leadership roles within the company’s Sales and Customer Solutions Management Groups, including leading its Global Sales Operations organization as well as serving as global lead for several large, strategic accounts. Prior to QuintilesIMS, Costa held various roles in the pharmaceutical division at Bayer. Outside of his professional career, Costa is active in his local community and serves as director for the North Carolina Public School Forum.

Costa earned a bachelor of science in biology from Brown University and his MBA from the University of Chicago, Booth School of Business. 
Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Delivery Excellence

Optimizing the customer experience through innovative solutions implemented with premium service that accelerates drug development outcomes

Read More